28539075|t|Fatigue in multiple sclerosis: Associations with clinical, MRI and CSF parameters
28539075|a|Damage of different brain structures has been related to fatigue. Alternatively, functional alterations of central nervous system (CNS) cells by the inflammatory milieu within the CNS may be responsible for the development of fatigue. To investigate the effect of structural brain damage and inflammatory cerebrospinal fluid (CSF) changes on fatigue in multiple sclerosis (MS). We determined the association of different clinical, CSF and magnetic resonance imaging (MRI) parameters with prevalence and severity of fatigue, as measured by the Fatigue Scale for Motor and Cognitive Functions in 68 early MS patients (discovery cohort). We validated our findings in two MS cohorts: the MRI validation cohort (N = 233) for the clinical and MRI parameters, and the CSF validation cohort (N = 81) for the clinical and CSF parameters. Fatigue was associated with clinical disability. Fatigue did not correlate with any CSF parameter but correlated negatively with total and cortical grey matter volume. However, when controlling for Expanded Disability Status Scale (EDSS) in a multivariate model, these associations lost significance. Disability and disease duration best explain fatigue severity but none of the tested MRI or CSF parameter was reliably associated with fatigue.
28539075	0	7	Fatigue	T184	C0015672
28539075	11	29	multiple sclerosis	T047	C0026769
28539075	31	43	Associations	T080	C0439849
28539075	49	57	clinical	T080	C0205210
28539075	59	62	MRI	T060	C0024485
28539075	67	70	CSF	T031	C0007806
28539075	71	81	parameters	T077	C0549193
28539075	82	88	Damage	T037	C0270611
28539075	102	118	brain structures	T023	C0006104
28539075	128	135	related	T080	C0439849
28539075	139	146	fatigue	T184	C0015672
28539075	163	173	functional	T169	C0205245
28539075	174	185	alterations	T078	C1515926
28539075	189	211	central nervous system	T022	C3714787
28539075	213	216	CNS	T022	C3714787
28539075	218	223	cells	T025	C0007634
28539075	231	243	inflammatory	T169	C0333348
28539075	244	250	milieu	T082	C0014406
28539075	262	265	CNS	T022	C3714787
28539075	293	304	development	T169	C1527148
28539075	308	315	fatigue	T184	C0015672
28539075	320	331	investigate	T169	C1292732
28539075	336	345	effect of	T080	C1704420
28539075	346	356	structural	T082	C0678594
28539075	357	369	brain damage	T037	C0270611
28539075	374	386	inflammatory	T169	C0333348
28539075	387	406	cerebrospinal fluid	T031	C0007806
28539075	408	411	CSF	T031	C0007806
28539075	413	420	changes	T169	C0392747
28539075	424	431	fatigue	T184	C0015672
28539075	435	453	multiple sclerosis	T047	C0026769
28539075	455	457	MS	T047	C0026769
28539075	478	489	association	T080	C0439849
28539075	503	511	clinical	T080	C0205210
28539075	513	516	CSF	T031	C0007806
28539075	521	547	magnetic resonance imaging	T060	C0024485
28539075	549	552	MRI	T060	C0024485
28539075	554	564	parameters	T077	C0549193
28539075	570	580	prevalence	T081	C0220900
28539075	585	593	severity	T080	C0392364
28539075	597	604	fatigue	T184	C0015672
28539075	609	617	measured	T080	C0444706
28539075	625	672	Fatigue Scale for Motor and Cognitive Functions	T170	C0349674
28539075	679	684	early	T079	C1279919
28539075	685	687	MS	T047	C0026769
28539075	688	696	patients	T101	C0030705
28539075	698	714	discovery cohort	T098	C0599755
28539075	734	742	findings	T033	C0243095
28539075	750	752	MS	T047	C0026769
28539075	753	760	cohorts	T098	C0599755
28539075	766	769	MRI	T060	C0024485
28539075	770	787	validation cohort	T098	C0599755
28539075	806	814	clinical	T080	C0205210
28539075	819	822	MRI	T060	C0024485
28539075	823	833	parameters	T077	C0549193
28539075	843	846	CSF	T031	C0007806
28539075	847	864	validation cohort	T098	C0599755
28539075	882	890	clinical	T080	C0205210
28539075	895	898	CSF	T031	C0007806
28539075	899	909	parameters	T077	C0549193
28539075	911	918	Fatigue	T184	C0015672
28539075	923	938	associated with	T080	C0332281
28539075	939	947	clinical	T080	C0205210
28539075	948	958	disability	T033	C0231170
28539075	960	967	Fatigue	T184	C0015672
28539075	972	975	not	T169	C1518422
28539075	976	985	correlate	T080	C1707520
28539075	995	998	CSF	T031	C0007806
28539075	999	1008	parameter	T077	C0549193
28539075	1013	1023	correlated	T080	C1707520
28539075	1024	1034	negatively	T033	C1513916
28539075	1040	1045	total	T080	C0439810
28539075	1050	1058	cortical	T023	C0007776
28539075	1059	1070	grey matter	T024	C0018220
28539075	1071	1077	volume	T081	C0449468
28539075	1093	1104	controlling	T067	C2239193
28539075	1109	1141	Expanded Disability Status Scale	T170	C0451246
28539075	1143	1147	EDSS	T170	C0451246
28539075	1154	1166	multivariate	T080	C0681923
28539075	1167	1172	model	T170	C3161035
28539075	1180	1192	associations	T080	C0439849
28539075	1193	1197	lost	T169	C0745777
28539075	1198	1210	significance	T078	C0750502
28539075	1212	1222	Disability	T033	C0231170
28539075	1227	1234	disease	T047	C0012634
28539075	1235	1243	duration	T079	C0449238
28539075	1257	1264	fatigue	T184	C0015672
28539075	1265	1273	severity	T080	C0392364
28539075	1290	1296	tested	T169	C0039593
28539075	1297	1300	MRI	T060	C0024485
28539075	1304	1307	CSF	T031	C0007806
28539075	1308	1317	parameter	T077	C0549193
28539075	1331	1346	associated with	T080	C0332281
28539075	1347	1354	fatigue	T184	C0015672